ClinicalTrials.gg
CompletedNCT05918354SPAT_AIUpdated Oct 16, 2024

Development and Evaluation of an Artificial Intelligence Model for the Diagnosis of Aeroallergies

An observational study in Allergy, sponsored by Hippocreates. Completed at 6 sites in 2 countries. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-10-16.

Sponsored by Hippocreates · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
993
Ages
18 Years and older
Sex
All
01

Study summary

To improve accuracy and take out human error, Hippo Dx previously developed S.P.A.T., an automated skin prick test. Now, Hippo Dx will develop and evaluate a S.P.A.T. artificial intelligence (AI) medical software to support physicians in the read out of the test results from an automated skin prick test.

In this study 700 images will be collected to develop the AI model, an additional 200 images will be collected to evaluate performance of the AI model. In a last independent cohort of 100 patients, performance of read-out by the physician will be compared with read out by the physician supported by the S.P.A.T. AI medical software.

The primary endpoint is the accuracy of the maximal wheal size measurement by S.P.A.T. AI versus the maximal wheal size measurement by the physician.

It is a prospective multicentric study that will include 1000 study participants from different countries.

02

Conditions studied

  • Allergy

Browse trials for

03

In context

Hypersensitivity

1,925 studies on the registry are indexed under Hypersensitivity; 261 are open to participants now.

This study's enrollment of 993 is above the median of 113 across 482 observational studies indexed under Hypersensitivity.

Browse Hypersensitivity studies →

Lead sponsor

Hippocreates is the lead sponsor of 3 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Adults aged 18 years or above, consulting the outpatient clinic for an allergy diagnosis to aeroallergens will be included.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

- Adults aged 18 years or above, consulting the outpatient clinic for an allergy diagnosis to aeroallergens will be included.

Exclusion criteria

Exclusion Criteria:

  • Skin pathology like chronic or exuberant urticaria, dermographism, chronic dermatitis that needs daily treatment
  • Use of antihistaminic medication \< 7 days before the start of the study
  • Use of tricyclic antidepressants (antihistamine activity) \< 7 days before the start of the study
  • Use of topical corticoids on the forearm \< 7 days before the start of the study
  • Use of Omalizumab \< 6 months before the start of the study
  • Pregnancy: there is a remote possibility of inducing a systemic allergic reaction that could induce uterine contractions or necessitate the use of epinephrine (thought to cause constriction of the umbilical artery)
  • Incapacitated individuals
  • Individuals who do not speak the local language (Dutch - French)
  • Individuals who cannot read or write
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
993 participants (actual)
Patient registry
No

Groups and cohorts

  • Allergy

    Adults aged 18 years or above, consulting the outpatient clinic for an allergy diagnosis to aeroallergens with skin prick automated test device.

    Device: Skin Prick Automated Test

Interventions

  • DeviceSkin Prick Automated Test

    Detection of sensitisation to specific allergens via the skin prick automated test.

06

What researchers measure

Primary outcomes

  1. Equivalency of S.P.A.T. artificial intelligence versus physician

    The equivalency of the maximal wheal diameter as measured by S.P.A.T. AI versus the maximal wheal diameter as assessed by the physician.

    Time frame: 15 minutes after the diagnostic test

Secondary outcomes

  1. Precision of S.P.A.T. artificial intelligence versus physician

    Likelihood that the S.P.A.T. AI maximal wheal diameter measurement lays within the range of the maximal wheal size measurement of 3 independent physicians.

    Time frame: 15 minutes after the diagnostic test

  2. Intra-reader variability of S.P.A.T. read out by physicians

    Variation in maximal wheal size diameter of the same image by 3 independent physicians.

    Time frame: 15 minutes after the diagnostic test

  3. Comparison of different methods (maximal wheal diameter) of read out by S.P.A.T. artificial intelligence versus physician

    Accuracy of the maximal wheal diameter by S.P.A.T. AI versus the maximal wheal diameter measurement by the physician.

    Time frame: 15 minutes after the diagnostic test

  4. Comparison of S.P.A.T. artificial intelligence supporting the physician versus physician

    Inter-reader variability of read out of S.P.A.T. results by the physician supported by the S.P.A.T. AI software versus the physician alone.

    Time frame: 15 minutes after the diagnostic test

  5. Time impact of S.P.A.T. artificial intelligence supporting the physician versus physician

    Total time required to perform read out of S.P.A.T. results by the physician supported by the S.P.A.T. AI software versus the physician alone.

    Time frame: 15 minutes after the diagnostic test

  6. Comparison of different methods (mean - maximal wheal diameter) of read out by S.P.A.T. artificial intelligence versus physician

    Accuracy of mean wheal diameter by S.P.A.T. AI versus the maximal wheal diameter measurement by the physician.

    Time frame: 15 minutes after the diagnostic test

  7. Comparison of different methods (wheal area - maximal wheal diameter) of read out by S.P.A.T. artificial intelligence versus physician

    Accuracy of wheal area by S.P.A.T. AI versus the maximal wheal diameter measurement by the physician.

    Time frame: 15 minutes after the diagnostic test

  8. Comparison of different methods (HEP index - maximal wheal diameter) of read out by S.P.A.T. artificial intelligence versus physician

    Accuracy of HEP-index measurement by S.P.A.T. AI versus the maximal wheal diameter measurement by the physician.

    Time frame: 15 minutes after the diagnostic test

07

Study locations

6 sites
  • Clinique Universitaires Saint-Luc
    Brussels, 1200, Belgium
  • Ziekenhuis Oost Limburg
    Genk, 3500, Belgium
  • UZ Leuven
    Leuven, 3000, Belgium
  • CHU de Liège
    Liège, 4000, Belgium
  • GZA ziekenhuizen
    Wilrijk, 2610, Belgium
  • Klinikum rechts der Isar
    Munich, 81675, Germany
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 16, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05918354
Lead sponsor
Hippocreates
Responsible party
Sponsor
First posted
Jun 26, 2023
Start date
Jul 10, 2023
Primary completion
Sep 11, 2024
Completion
Sep 11, 2024
Last update
Oct 16, 2024

Study contacts

Mark Jorissen, MD, PhD
principal investigator · UZ Leuven

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion